Hasil Pencarian
	Ditemukan 1569 dokumen dengan kata kunci 6390 Simpan CSV  FOLFOX4 plus cetuximab administered weekly or every second week in the first-line treatment of patients with KRAS wild-type metastatic colorectal cancer: a randomized phase II CECOG study No. Panggil: Annals of Oncology; Volume 24, No.7, Juli, 2013, p.1769-1777 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Panitumumab combined with irinotecan for patients with KRAS wild-type metastatic colorectal cancer refractory to standard chemotherapy: a GERCOR efficacy, tolerance, and translational molecular study No. Panggil: Annals of Oncology; Volume 24, No.2, February,2013,p.412-419 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Capecitabine/irinotecan or capecitabine/oxaliplatin in combination with bevacizumab is effective and safe as first-line therapy for metastatic colorectal cancer: a randomized phase II study of the AIO colorectal study group No. Panggil: Annals of Oncology; Volume 24, No.6, June, 2013, p.1580-1587 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Bevacizumab plus chemotherapy continued beyond first progression in patients withmetastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings† No. Panggil: Annals of Oncology; Volume 24, No.9, September, 2013, p.2342-2349 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT Trial No. Panggil: Annals of Oncology; Volume 24, No.9, September, 2013, p.2335-2341 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer† No. Panggil: Annals of Oncology; Volume 24, No.7, Juli, 2013, p.1792-1801 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Optimally tolerated dose of lapatinib in combination with docetaxel plus trastuzumab in first-line treatment of HER2-positive metastatic breast cancer No. Panggil: Annals of Oncology; Volume 24, No.8, August, 2013,p.2005-20011 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma No. Panggil: Annals of Oncology; Volume 24, No.6, June, 2013, p.1567-1573 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Regorafenib in combination with FOLFOX or FOLFIRI as first- or second-line treatment of colorectal cancer: results of a multicenter, phase Ib study No. Panggil: Annals of Oncology; Volume 24, No.6, June, 2013, p.1560-1567 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Age-dependent improvement in median and long-term survival in unselected population-based Nordic registries of patients with synchronous metastatic colorectal cancer No. Panggil: Annals of Oncology; Volume 24, No.9, September, 2013, p.2354-2360 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Prev   1 2 3 4 5 6 7 8 9 10  Next